Skip to main content
. 2019 May 16;26(1):551–565. doi: 10.1080/10717544.2019.1616235

Figure 4.

Figure 4.

Chemical structures and molecular weight of (A) approved small-molecule drugs (710) re-positioned as anti-GBM agents and (B) imidazolium-based candidate molecules (1116) with promising BBB permeability.